N-Ethylpentylone

4-CEC

Ethylone

Pentylone

SYNTHETICCANNABINOIDS CATHINONES

OPIOIDS/ANALGESICS

EMERGING THREAT REPORT 2017 Drug Enforcement Administra�onSpecial Testing and Research Laboratory

Questions about this data are welcome and may be directed to the DEA Emerging Trends Program at 703-668-3300 or DEA.Emerging.Trends@usdoj.gov

US Department of. . Justice

Drug Enforcement Admini

stra

tion

.

HALLUCINOGENS

OTHER

Fourth Quarter

FOR OFFICIAL USE ONLY

THERE WERE 2 IDENTIFICATIONS OF 25I-NBOME AND 1IDENTIFICATION OF 2C-B DURING THE REPORTING PERIOD.

TRYPTAMINES

NO SUBSTITUTED TRYPTAMINES WERE IDENTIFIED DURING THE REPORTING PERIOD.

THERE WERE 3 INSTANCES OF UNCONFIRMED

SUBSTANCES THIS QUARTER. THERE WERE 3

IDENTIFICATIONS OF 3-METHOXY-PCP AND 3IDENTIFICATIONS OF MITRAGYNINE. THERE WERE 2 IDENTIFICATIONS EACH OF 3-FLUOROPHENMETRAZINE, 5-EAPB, 5-MAPB, FLUBROMAZOLAM, METHOXETAMINE,

METHOXPHENIDINE, AND PHENAZEPAM. THERE WAS 1 IDENTIFICATION OF pFPP DURING THIS REPORTING PERIOD.

THERE WERE 17 CATHINONE IDENTIFICATIONS THIS

REPORTING PERIOD. N-ETHYLPENTYLONE WAS THE MOST

REPORTED CATHINONE, ACCOUNTING FOR APPROXIMATELY

76% OF THE IDENTIFICATIONS.

THERE WERE 311 IDENTIFICATIONS OF FENTANYL, FENTANYL-

RELATED COMPOUNDS, AND OTHER NEW OPIOIDS. FENTANYL

ACCOUNTED FOR 66% OF THE IDENTIFICATIONS. THE NEXT MOST PROMINENT SUBSTANCE WAS 4-ANPP WHICH ACCOUNTED

FOR APPROXIMATELY 7% OF THE IDENTIFICATIONS. THIS IS THE FIRST TIME 4-ANPP HAS BEEN THE SECOND MOST PREVALENT

FENTANYL-RELATED COMPOUND. OF THE 204 FENTANYL IDENTIFICATIONS, FENTANYL WAS FOUND AS THE ONLY

CONTROLLED SUBSTANCE IN 50% OF THE IDENTIFICATIONS

AND WAS FOUND WITH HEROIN IN 39% OF THEIDENTIFICATIONS.

The Special Tes�ng and Research Laboratory’s Emerging Trends Program compiled the data for this report through a query of archived seizure and analysis informa�on from drug evidence analyzed by the Drug Enforcement Administra�on’s laboratory system. This data is representa�ve of drug evidence seized and analyzed in the date ranges annotated. This is not a comprehensive list of all new psychoac�ve substances and is not representa�ve of all evidence analyzed

by DEA. This data is a quarterly snapshot of the new psychoac�ve substance market in the United States.

The term new psychoac�ve substance (NPS) describes a recently emerged drug that may pose a public health threat. This includes synthe�c cannabinoids, subs�tuted cathinones, phenethylamines, opioids, tryptamines, benzodiazepines, and a variety of other chemical classes. Due to the recent increase in seizures, fentanyl is also included in this report.

An iden�fica�on is made when authen�cated reference material is available for comparison. When reference material is not available, the drug evidence is iden�fied as “substance unconfirmed”. A single unit of drug evidence may have mul�ple sub-units. For the purposes of this document, each unit of drug evidence counts as one iden�fica�on regardless of the number of sub-units. Some seized drug evidence contains more than one ac�ve ingredient; therefore, more than one iden�fica�on can be made for a single unit.

THERE WERE 43 SYNTHETIC CANNABINOID IDENTIFICATIONS

IN THE 4TH QUARTER OF CY2017. FUB-AMB WAS THE MOST REPORTED SYNTHETIC CANNABINOID, ACCOUNTING FOR

APPROXIMATELY 42% OF THE IDENTIFICATIONS. NO NEW

SYNTHETIC CANNABINOIDS WERE REPOR1 TED THIS QUARTER.

1

10

14

18

1

3

3

3

3

4

5

6

7

8

10

11

20

23

204

1

1

2

13

FUB-AMB

ADB-FUBINACA

5F-MDMB-PINACA

5F-UR 144

Fentanyl

4-ANPP

Methoxyacetylfentanyl

Furanyl fentanyl

U-47700

Cyclopropylfentanyl

Carfentanil

4-FiBF

Acetylfentanyl

U-49900

Acryl fentanyl

Benzylfentanyl

Butyryl fentanyl

U-48800

3-Methylfentanyl

CEC = Chloroethcathinone